DistressOther
Acorda Therapeutics, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Acorda Therapeutics, Inc. -> target · $20 million
The decision to file for Chapter 11 protection follows a lengthy strategic review during which the Company explored a wide range of strategic options.
Open source record (SEC) ↗